Andrea Botticelli

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 212 publications

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 14, 2026

Advancing breast cancer clinical management through technological innovation: the potential role of artificial intelligence and integrated care models.

Advancing breast cancer clinical management through technological innovation: the potential role of artificial intelligence and integrated care models.

Journal: ESMO open

Published: April 30, 2026

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

Journal: Nature communications

Published: April 15, 2026

Prolonged response to combined BRAF and MEK inhibition in BRAF mutant colorectal cancer, a case report.

Prolonged response to combined BRAF and MEK inhibition in BRAF mutant colorectal cancer, a case report.

Journal: Frontiers in oncology

Published: March 13, 2026

From site-centered to patient-centered: Promises and challenges of decentralized clinical trials in oncology.

From site-centered to patient-centered: Promises and challenges of decentralized clinical trials in oncology.

Journal: Critical reviews in oncology/hematology

Published: March 11, 2026

Cardiovascular and Renal Risk Stratification in Patients Referred to an Onconephrology Clinic and Undergoing Different Oncology Therapies: A Real-World Study.

Cardiovascular and Renal Risk Stratification in Patients Referred to an Onconephrology Clinic and Undergoing Different Oncology Therapies: A Real-World Study.

Journal: Biomedicines

Published: February 20, 2026

Real-world evidence of sacituzumab govitecan in metastatic triple-negative breast cancer: an updated multicenter analysis.

Real-world evidence of sacituzumab govitecan in metastatic triple-negative breast cancer: an updated multicenter analysis.

Journal: ESMO open

Published: February 02, 2026

Comprehensive genomic profiling in solid tumours: Navigating promise, challenges, and pathways to clinical integration.

Comprehensive genomic profiling in solid tumours: Navigating promise, challenges, and pathways to clinical integration.

Journal: Cancer treatment reviews

Published: January 31, 2026

Evaluation of Drug-Drug Interactions Using Drug-PIN® in Patients Receiving Avelumab Maintenance for Advanced Urothelial Carcinoma: Evidence from the MALVA Study (Meet-URO 25).

Evaluation of Drug-Drug Interactions Using Drug-PIN® in Patients Receiving Avelumab Maintenance for Advanced Urothelial Carcinoma: Evidence from the MALVA Study (Meet-URO 25).

Journal: Oncology and therapy

Published: January 26, 2026

Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.

Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 23, 2025

Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.

Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.

Journal: Breast (Edinburgh, Scotland)

Published: December 22, 2025

The role of the molecular tumor board: learnings from the ROME trial.

The role of the molecular tumor board: learnings from the ROME trial.

Journal: NPJ precision oncology

Published: November 18, 2025

Showing 1-12 of 212

Last Updated: 09/26/2026